Three different CT and FGD PET/CT findings of pulmonary involvement in methotrexate‐associated lymphoproliferative disease
| Autor: | Haruhito Sugiyama, Masayuki Hojo, Keita Sakamoto, Shinyu Izumi, Manabu Suzuki, Sachi Matsubayashi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
myalgia musculoskeletal diseases rheumatoid arthritis medicine.medical_specialty Diffuse large B‐cell lymphoma Epstein–Barr reactivation or Epstein–Barr infection methotrexate 03 medical and health sciences 0302 clinical medicine hemic and lymphatic diseases medicine Case Series skin and connective tissue diseases lcsh:RC705-779 PET-CT Lung medicine.diagnostic_test business.industry Nodule (medicine) lcsh:Diseases of the respiratory system psoriasis medicine.disease medicine.anatomical_structure 030228 respiratory system Positron emission tomography 030220 oncology & carcinogenesis Rheumatoid arthritis Methotrexate Radiology medicine.symptom business Diffuse large B-cell lymphoma medicine.drug |
| Zdroj: | Respirology Case Reports Respirology Case Reports, Vol 8, Iss 2, Pp n/a-n/a (2020) |
| ISSN: | 2051-3380 |
| Popis: | Lymphoproliferative disease (LPD) is one of the complications of methotrexate (MTX) therapy. In MTX‐associated LPD (MTX‐LPD), LPD lesions limited to the lungs are rare and show various types of opacity. A 75‐year‐old woman with rheumatoid arthritis (RA) presented with myalgia. She had been taking MTX for 11 years. Chest computed tomography (CT) scans showed a nodule in the left lower lobe that had grown significantly and a new nodule in the right lower lobe. 18F‐fluorodeoxyglucose (FDG)/positron emission tomography (PET)/CT revealed significant FDG uptake in these nodules. Transbronchial biopsy specimen showed diffusely distributed CD20‐positive lymphoid cells, and we made a diagnosis of MTX‐LPD. All lung lesions disappeared within months after the immediate discontinuation of MTX. We also had two other patients with MTX‐LPD lung lesions that had high FDG uptake. FDG PET/CT might be a useful diagnostic tool as it may reflect disease progression and help identify separate lesions. Methotrexate (MTX) is one of the key drugs for treating rheumatoid arthritis (RA) and other autoimmune arthritis. Lymphoproliferative disease (LPD) is a complication of low‐dose MTX therapy. We describe three cases of MTX‐LPD where we conducted chest computed tomography (CT) and 18F‐fluorodeoxyglucose (FDG)/positron emission tomography (PET)/CT. This report focuses on the radiological findings of MTX‐LPD, including FDG PET/CT, based on these cases. FDG PET/CT might be a useful diagnostic tool as it may reflect disease progression and help identify separate lesions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text